Arthur J. Higgins

2018 - DepoMed

In 2018, Arthur J. Higgins earned a total compensation of $4.8M as President and Chief Executive Officer at DepoMed, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$754,752
Salary$800,000
Stock Awards$3,159,936
Other$69,339
Total$4,784,027

Higgins received $3.2M in stock awards, accounting for 66% of the total pay in 2018.

Higgins also received $754.8K in non-equity incentive plan, $800K in salary and $69.3K in other compensation.

Rankings

In 2018, Arthur J. Higgins' compensation ranked 2,145th out of 14,244 executives tracked by ExecPay. In other words, Higgins earned more than 84.9% of executives.

ClassificationRankingPercentile
All
2,145
out of 14,244
85th
Division
Manufacturing
776
out of 5,759
87th
Major group
Chemicals And Allied Products
258
out of 2,122
88th
Industry group
Drugs
206
out of 1,811
89th
Industry
Pharmaceutical Preparations
159
out of 1,385
89th
Source: SEC filing on April 8, 2019.

Higgins' colleagues

We found six more compensation records of executives who worked with Arthur J. Higgins at DepoMed in 2018.

2018

Stanley Bukofzer

DepoMed

Senior Vice President and Chief Scientific and Technical Officer

2018

Phillip Donenberg

DepoMed

Chief Financial Officer

2018

August Moretti

DepoMed

Chief Financial Officer

2018

Matthew Gosling

DepoMed

General Counsel

2018

Santosh Vetticaden

DepoMed

Chief Medical Officer

2018

Daniel Peisert

DepoMed

Chief Financial Officer

News

You may also like